Femto Technologies Secures $17 Million in Private Placement to Advance Feminine Wellness Innovation

Femto Technologies Inc. (Nasdaq:FMTO), a FemTech company and creator of the Sensera feminine wellness product, has successfully closed a private placement raising approximately $17 million through the sale of Common Units and warrants. The offering involved 4,076,736 Common Units priced at $4.17 per unit, with each unit consisting of one Common Share or Pre-Funded Warrant, one Series A Warrant, and one Series B Warrant. The Pre-Funded Warrants are immediately exercisable, while the Series A Warrants carry a $5.21 exercise price and 60-month term, and the Series B Warrants feature a $12.51 exercise price with a 30-month term.

The significance of this funding extends beyond the immediate capital infusion, as it enables Femto to accelerate the development of its proprietary Smart Release System technology that incorporates machine learning and artificial intelligence. This technology, which earned Sensera recognition as a CES Innovation Awards® 2025 honoree in the AI category, represents a pioneering approach to feminine wellness that bridges the gap between feminine pleasure and holistic self-care. The company plans to use the net proceeds for general corporate purposes and working capital, potentially accelerating product development and market expansion efforts.

The private placement transaction, which closed on February 28, 2025, was conducted as a non-public offering to accredited investors only, with securities sold pursuant to exemptions from registration requirements under the Securities Act of 1933. Aegis Capital Corp. served as exclusive placement agent for the offering, with legal representation provided by Louis A. Brilleman, P.C. for the company and Kaufman & Canoles, P.C. for Aegis Capital Corp. The company has agreed to file registration statements with the SEC to facilitate potential future resale of the securities, as detailed in the registration rights agreement with investors.

This financing round matters because it provides essential capital for a company operating in the rapidly growing FemTech sector, which addresses significant gaps in women's health technology and wellness products. The funding supports the advancement of AI-driven solutions that could transform how women approach their wellness needs, particularly through products like Sensera that adapt to changing physiological requirements. For more information about the company's regulatory filings and financial disclosures, investors can review documents available at https://www.sedarplus.ca.

The successful completion of this $17 million offering demonstrates investor confidence in Femto's technology and business strategy during a period when FemTech companies are gaining increased attention for addressing underserved markets in healthcare technology. The capital raised positions the company to potentially accelerate its research and development activities while navigating the regulatory landscape required for bringing innovative feminine wellness products to market.